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Instruction: Acute pulmonary thromboembolism (APTE) is a common clinical condition associated with signiﬁ-
cant morbidity andmortality. Although promising, bone marrow-derivedmesenchymal stem cell (BMSC) treat-
ment for thrombus resolution remains controversial. The therapeutic effectiveness of BMSC against APTE has not
been evaluated. This study aims to determine whether BMSCs administration is effective in mouse model.
Materials andMethods: Therapeutic efﬁcacy of female andmale BMSCswere evaluated by applying serial section-
ing analysismethod for thewhole lungs of APTEmice and calculating each thrombus size in volume. Plasmid con-
struction and stable transfection were used to manipulate expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) in both genders of BMSCs. Western blot were performed to detect GAPDH and uroki-
nase plasminogen activator expression in BMSCs.
Results:Our data showed, 1) comparedwith non-serial sectioningmethod, the serial sectioningmethod detected
more thrombi, larger size ranges of thrombus area, and the volume of each individual thrombus. 2) BMSCs
signiﬁcantly decreased the thrombi size in APTE mice, with female BMSCs superior to male ones. 3) female
BMSCs showed a higher GAPDH protein level and manipulations of GAPDH expression in female or male
BMSCs profoundly affected their therapeutic efﬁcacies as well as urokinase plasminogen activator expression.
Conclusion: This study indicates serial-sectioning analysis method is necessary for evaluating APTE and provides
strong evidences for BMSCs possessing therapeutic effectiveness against APTE, with female BMSCs superior to
male counterparts. GAPDH played a critical role in the superior function of female BMSCs, possibly by regulating
the expression of urokinase plasminogen activator.© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Acute pulmonary thromboembolism (APTE) is a life-threatening
emergency, associated with signiﬁcant morbidity and mortality [1].bolism; BMSCs, bone marrow-
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. This is an open access article underHowever, because of bleeding complications, fragmentation and some
clinical dilemmas, therapeutic efﬁcacy of the available treatments
including anticoagulation and thrombolytic management is unsatisfac-
tory [2]. Therefore, developing new treatment strategies for APTE is re-
quired. To develop and evaluate new treatment approach, appropriate
animal models as well as analysis methods for APTE are fundamental
and necessary.
To the best of our knowledge, there are only a few mouse models
for APTE. It was reported that APTE mouse models induced by a
single intravenous injection of a thrombogenic stimulus (collagen plus
epinephrine) resulted in high mortality [3]. Contrarily, our previous
work showed that thrombi injection was a stable and feasible way to
create APTE mouse model [4]. Though there is a conventional method
for determining the size of solitary deep vein thrombus by calculatingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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300-μm intervals [5,6], few studies investigated the size of multiple
PTEs. Therefore, we performed serial sectioning of all pulmonary lobes
and determined each thrombus size using volume instead of area. We
further compared this analysis method with its conventional counter-
part. The data demonstrated that the serial sectioning analysis method
provided more objective and exhaustive data on the number, as well as
size of thrombi in APTE mice.
Stem cell therapy is a novel and important treatment modality
in clinical medicine that can be used against many diseases [7].
Meanwhile, there is growing concern regarding the safety of stem cell
therapy. Several clinical studies indicated that the intravascular
administration of stem cells may increase the risk for developing PTE
[8,9]. A recent investigation in a mouse model indicated signiﬁcant
procoagulation and resulting PTE after stem cell administration [10].
However, there are also studies indicating that stem cells could facilitate
thrombus resolution [11–13]. Modarai B et al reported that bone
marrow-derived endothelial progenitor cells (EPC) were recruited into
resolving venous thrombi [11]. These cells could contribute to thrombus
recanalisation by expressing a variety of proangiogenic cytokines or by
lining the new vessels that appeared within the thrombus [12]. A later
investigation in 28 athymic nude rats with thrombus induction showed
that intravenous administration of EPC resulted in signiﬁcantly
enhanced thrombus neovascularization and therefore facilitated throm-
bus resolution [13]. To our knowledge, the effect of bone marrow-
derivedmesenchymal stem cells (BMSCs) transplantation onpreviously
existed PTE has not been evaluated.
Moreover, gender differences of stem cells on therapeutic efﬁciency
had aroused much attention in recent years. Some studies showed
superiority of female stem cells on fat augmentation [14] or against
ischaemia/reperfusion injury [15]. However, another important study
demonstrated a better therapeutic potential of male stem cells in an
articular cartilage defect model [16]. Our latest work reported superior
efﬁcacy of female BMSCs from C57BL/6 J mice against monocrotaline-
induced pulmonary hypertension. Furthermore, in that study we
accidently found a signiﬁcantly higher expression of glyceraldehyde-
3-phosphate dehydrogenas (GAPDH) in female BMSCs and veriﬁed
GAPDH played a critical role in the superior therapeutic efﬁcacy of
female BMSCs against pulmonary hypertension [17]. The discrepancies
about gender difference on stem cell therapy implied that it might be
disease or tissue speciﬁc [17]. Up to now, there is no report about sex
differences of BMSCs treatment on APTE.
Facing these contradictions and unknown issues, in this study, we
developed an analysis method using the serial sectioning of the entire
lung in mouse models to determine whether BMSCs can aggravate or
ameliorate the formation of existing, multiple PTEs and, to detect
whether there were gender differences about BMSCs treatment against
APTE. The urokinase-type plasminogen activator (u-PA) production
was critically involved in bone marrow transplantation-associated
early thrombus resolution [11], we further explored if u-PA can be the
mechanism underlying the potential gender difference of BMSCs as
the downstream target of GAPDH.
Materials and Methods
Ethics Statement and the Animals Used
C57BL/6 J mice were used for stem cell isolation and transplantation
as well as APTE models. All animal experiments were approved by the
Institutional Animal Care and Use Committee.
Primary Culture and Identiﬁcation of BMSCs
The isolation, identiﬁcation and maintenance of BMSCs were per-
formed as we described before [17]. Brieﬂy, BMSCs were obtained
from the bone marrow of 3- to 4-week-old female and male C57BL/6 Jmice by ﬂushing the femur and tibia diaphyses with Dulbecco’s modi-
ﬁed Eagle’smedium (DMEM) andwere cultured in DMEM supplement-
ed with 20% fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/
ml streptomycin. BMSCs at passage 3 were homogenous and appeared
in long rhombus shape. Then the cells were trypsinized (0.25% trypsin)
and adjusted to the density of 2 × l06/ml, and then incubated with
ﬂuorescence-conjugated antibodies for CD29, CD34, CD45 and their
isotype controls in a black chamber at 4 °C for 30 min, respectively;
afterwashingwith PBS, cells analysiswasperformedwith aﬂow cytom-
etry (Becton Dickenson, USA) for further characterization of BMSCs.In Vivo Experimental Protocol
One day before the experiment, autologous thrombi were prepared
with the following procedures. 200 μl plasma was collected from
C57BL/6 J mouse tail and mixed with 50 μl thrombin CaCl2 mixtures
(10 U/ml bovine thrombin containing 0.5 mmol/L CaCl2). By aspirating
themixture into a glass catheter (1.2 mm in inner diameter), the autol-
ogous thrombus was made and then stabilized for 10 min at room
temperature, 30 min at 37 °C water bath, and stored at 4 °C overnight.
The thrombus was cut into 1 mm long pieces (autologous thrombi)
before use.
Under anaesthesia with ketamine (100 mg/kg) and xylazine
(10 mg/kg) by intraperitoneal injection, female and male C57BL/6 J
mice, 20-23 g, 6-8 weeks old, received an intravenous injection of 30
autologous thrombi with 0.4 ml saline via the right jugular vein to
produce the APTE model [4,18]. Then, the APTE mice were either not
treated or treated with female or male BMSCs (2 × 106 cells in 0.5 ml
PBS via tail vein) in a sex-matched or a sex-mismatched way at 4 h,
8 h, or 16 h after thrombi injection. The experimental groups studied
in either gender mice and each time point were as follows: 1) PTE
mice treated with PBS (control group), 2) PTE mice treated with female
BMSCs (F-BMSCs group), and 3) PTE mice treated with male BMSCs
(M-BMSCs group). One day after thrombi injection, the mice were
sacriﬁced, and the lungs were collected for further analysis.Measurement of Thrombus Size
After the lungswere ﬁxed in 10% formalin and embedded in parafﬁn,
5-μm-thick serial sections were obtained from whole lung lobes and
stainedwith hematoxylin and eosin (H&E). Digital images of all thrombi
in the sections were captured at × 100 magniﬁcation (Nikon Imaging).
The acquisition, spatial calibration, and analysis of the captured
images were achieved using Image-Pro Plus analysis software (Media
Cybernetics UK, Berkshire, UK). As for the serial sectioning analysis
method, the size of each thrombus was calculated and recorded by vol-
ume. Brieﬂy, we collected all the serial H&E pictures of each thrombus.
The total area of one thrombus in all the serial pictures multiplying by
section thickness (5 μm) equals the volume of this thrombus (Fig. 1A).
For comparison, we also recorded the size of thrombi by calculating
the sum of the thrombus areas in all selected sections cut at 300-μm
intervals as the conventional method previously reported [5,6].Lung Biopsy of Patients
The study protocol using lung biopsy of patients was approved by
the Institutional Research Ethics Committee. 3 biopsy embedded blocks,
one for each of the three patients of pulmonary infectionwith suspected
PTE were collected from the forensic department for the current study.
The blocks of ~ 1.0 cm×1.0 cm×0.2 cm size for eachwere embedded in
parafﬁn and the 5 μm thick serial sections obtained were stained with
H&E. The thrombus number, thrombus size, and size distributions
from serial analysis method were compared with those from non-
serial analysis counterpart.
Fig. 1. Analysis ofPTE size using twoanalysismethods inAPTEmice. (A) All the serial HE pictures of one thrombus. The sumof all the thrombus areas in all the serial picturesmultiplying
by section thickness (5 μm) equals the volume of this thrombus. The area of the thrombus in each picturewas as follows: A1, 3666 μm2, A2, 15901 μm2, A3, 19036 μm2, A4, 14617 μm2, A5,
11536 μm2, A6, 14886 μm2, A7, 20871 μm2, A8, 20016 μm2, A9, 22826 μm2, A10, 24007 μm2, A11, 32446 μm2, A12, 22157 μm2, A13, 17583 μm2, A14, 3925 μm2, and the volume of this
thrombus was (3666 + 15901 + 19036 + 14617 + 11536 + 14886 + 20871 + 20016 + 22826 + 24007 + 32446 + 22157 + 17583 + 3925) μm2 × 5 μm = 1.22× 106 μm3.
(B) Using the serial sectioning analysis method and PTE volume calculation, the volumes of 165 PTEs in male and female mice were divided into 5 categories: b0.1, 0.1-1, 1-5, 5-10,
and N10× 106 μm3. (C) Summarization of the frequency distribution of the thrombus size in both female andmale PTEmice. (D) Using the conventionalmethodwith non-serial sectioning
at 300-μm intervals and PTE area calculation, there were 76 PTEs, the sizes of which were distributed into the categories 1-5, 5-10, N10 × 103 μm2. (E) Summarization of the frequency
distribution of the thrombus size in both female andmale PTEmice. (F) Comparison ofmean area, meanmaximal area andmeanminimal area of PTEs between the two analysismethods.
(male mice, n = 42; female mice, n = 42).
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The whole lungs from female and male APTE mice were ﬁxed and
embedded for serial sectioning. All the serial sections of each thrombuswere numbered in consecutive order separately. Every fourth sections
were stained with H&E for morphological identiﬁcation of the presence
of thrombus. Their intervening sections were kept and processed for
immunohistochemically staining with antibodies against three major
993X. Peng et al. / Thrombosis Research 135 (2015) 990–999components of thrombus: glycoprotein (GP) IIb/IIIa (anti-CD41/CD61
antibody, abcam) for detecting platelet trabeculae, glycophorin A
(anti-glycophorin A antibody, abcam) for erythrocytes [19], and
Martius, Scarlet, Blue (MSB) staining for ﬁbrin [20].
The positively stained areas of GPIIb/IIIa, ﬁbrin, glycophorin A
were captured and analyzed respectively by a confocal microscope
(OLYMPUS IX-300, Japan) and Image-Pro Plus analysis software
(Media Cybernetics UK, Berkshire, UK). The expression of these proteins
(GPIIb/IIIa, ﬁbrin, glycophorin A) was quantiﬁed as a ratio of positively
stained areas per thrombus area [19].
Plasmid and Stable Transfection
Female and male BMSCs were separately seeded in a 6-well plate in
DMEM supplemented with 10% FBS. Female BMSCs undergoing expo-
nential growth were concurrently transfected with 2 μg siRNA-vector
(pGCsilencerTMU6/Neo/GFP/RNAi vector from the GenechemCorpora-
tion, Shanghai, China) for the female control group and siRNA-GAPDH
(pGCsilencerTM U6/Neo/GFP/RNAi-GAPDH from the Genechem Corpo-
ration, Shanghai, China) for the female siRNAgroup.Male BMSCs under-
going exponential growth were transfected with the overexpression
vector (pIRES2-ZsGreen1 vector, BioWit Technologies Ltd, Shenzhen,
China) for themale control group and theGAPDHoverexpression vector
(pIRES2-ZsGreen1-GAPDH, BioWit Technologies Ltd, Shenzhen, China)
for themale GAPDH-overexpression group. Transfectionwas performed
using the Lipofectamine 2000 reagent (catalogue number: 11668-027,
Invitrogen, CA, USA) according to the manufacturer’s recommenda-
tions. At 48 h after transfection, the cells were trypsinized and plated
for clonal selection of stable transfectants in 400 μg/ml G-418. Several
clones with good expression of the genes were selected out of 48
individual clones in each group.
Western Blot Analysis
Whole cell protein samples were prepared by lysing the desired
female and male BMSCs with or without stable transfection of the
above plasmids. Equal amounts of protein extracted from all samples
were western-blotted for speciﬁc antibodies against GAPDH (catalogue
number: 2118, Cell Signaling Technologies, Beverly, MA, USA) and u-PA
(catalogue number: sc-14019, Santa Cruz Biotech, Santa Cruz, CA, USA)
according to the manufacturer’s instructions. β-actin (catalogue
number: BM0627, (Wuhan boster Biological Engineering Co., Ltd.
Wuhan, China) served as control for equal protein loading.
Detection of BMSC Implantation in the Thrombus
4 h after autologous thrombi injection, GFP-expressing BMSCs were
transplanted into the PTEmice. Themice were sacriﬁced 20 h later, and
whole lungs were ﬁxed and embedded for serial sectioning. All the
serial sections were numbered in consecutive order. The odd-number
sections were stained with H&E to determine which sections included
a thrombus (termed as positive sections). The even-numbered sections
between two positive odd-numbered sections were then investigated
using immunoﬂuorescent staining with antibodies against GFP (GFP
Rabbit IgG Polyclonal Antibody Fraction, catalogue number: A11122,
Invitrogen) to detect whether there is BMSCs implantation in the
thrombi. Immunoﬂuorescence images were acquired using a confocal
microscope (OLYMPUS IX-300, Japan) and analyzed using Image-Pro
Plus analysis software (Media Cybernetics UK, Berkshire, UK).
Statistics Analysis
The data were expressed as the mean ± SEM and analyzed
using SPSS 12.0 statistical software (SPSS Inc., Chicago, Illinois, USA).
One-way analysis of variance followed by least signiﬁcant differencepost hoc analysis was used to determine the statistical signiﬁcance of
the differences between the means.
Results
Characterization of BMSCs
As we have previously described, mononuclear cells isolated from
female and male C57BL/6 J mice of the same litter bone marrow were
successfully expanded and characterized as BMSCs [17].
Analysis of Thrombi in the Lungs of APTE Mice
Based on previously reported methods [4,18], the APTE mouse
model was successfully produced by thrombi injection via the right
jugular vein. The mice were sacriﬁced at 24 h after thrombi injection,
and the lungs were collected for quantitative analysis of the thrombi
in the entire lung. In this study, we calculated the volume of each
thrombus in the lungs via serial sectioning of all pulmonary lobes
(Fig. 1A). With the serial-sectioning analysis method, we obtained 165
thrombi in total from the 84 APTEmice. According to thrombus volume,
we divided the thrombi into 5 categories: b0.1, 0.1-1, 1-5, 5-10,
N10 × 106 μm3. By frequency analysis of each size category (Fig. 1B),
we discovered that the size of most thrombi (129/165, 78.2%) ranged
from 0.1 to 5 (× 106 μm3) regardless of gender (Fig. 1C). Therefore,
the following analysis was derived using mainly experimental data ob-
tained from the thrombi at a size ranging from 0.1 to 5 (× 106 μm3). To
compare the serial-sectioning analysis method with the conventional
non-serial-sectioning analysis method, we also analyzed the size
of the thrombi by calculating the sum of thrombus areas in selected
non-serial sections at intervals of 300 μm. With this method, the total
number of thrombi obtained in the same 84 APTE mice was 76,
and the thrombus area was distributed within the 1-5, 5-10, and
N10 × 103 μm2 categories (Fig. 1D). According to frequency distribution
of size, most thrombi (62/76, 81.6%) were 1-10 × 103 μm2 (Fig. 1E).
Compared with this conventional non-serial analysis method, the serial
sectioning method detected 89 more thrombi (89/76, 117%) from the
same 84 APTE mice. Furthermore, by calculating the maximal area
and minimal area, we found a signiﬁcantly larger range of thrombus
size detected with serial sectioning method (from 28247.91 μm2 to
4231.25 μm2) versus that with conventional non-serial sectioning
method (from 12921.03 μm2 to 12571.67 μm2) (Fig. 1F).
Analysis of Anatomic Distribution of Pulmonary Thrombi (Including Lobular
and Vascular Distribution of PTE) in APTE Mice
In this study, we also analyzed the distribution of all the thrombi in
the lungs of both male and female mice via serial sectioning of every
pulmonary lobe. As shown in Table 1, out of 62 PTEs from all the male
mice, 32 (51.6%) were in the right lung (11 in upper, 2 in middle, and
19 in lower lobe), whereas 30 (48.4%) were in the left lung (29 in
upper and 1 in lower lobe). In the female mice group, 64 out of 103
(62.1%) were distributed in the right lung and 39 (37.9%) in the left.
The lobular distribution was as follows: 18 in right upper, 14 in right
middle, 32 in right lower, 35 in left upper, and 4 in left lower lobe. The
results indicated that regardless of mouse gender, the lower lobe of
the right lung possessed more PTEs than the middle or upper lobe; in
contrast, the upper lobe of the left lung contained more PTEs than the
lower lobe. We also studied the PTE distribution in the pulmonary
blood vessels. As indicated in Table 2, most PTEs were located in small
blood vessels with diameters less than 30 μm. Interestingly, the data
from the conventional non-serial sectioning analysis method demon-
strated similar thrombus distribution both in the pulmonary lobes and
blood vessels, though therewas a distinct decrease in thrombus number
(Table 1 and Table 2).
Table 1
Distribution of all PTEs in pulmonary lobes identiﬁed using two analysis methods.
PTEs distribution in pulmonary lobes male mice (n = 42) female mice (n = 42)
serial non-serial serial non-serial


































All PTE mouse models were analyzed using both the serial-sectioning analysis method and the conventional non-serial-sectioning analysis method.
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We collected 3 lung tissue blocks from 3 patients suspected of PTE.
Following the same procedure described above, wemade serial sections
of each lung tissue block. With the serial-sectioning analysis method,
78, 61 and 10 thrombi were found in the three lung tissue blocks,
respectively. According to thrombus volume calculated for each, the
thrombus size was divided into 5 categories: b0.1, 0.1-1, 1-10, 10-100,
N100 × 107 μm3 (Fig. 2A). Frequency analysis of thrombus size showed
most thrombi (74/149, 49.7%) ranged from 1 to 10 × 107 μm3) (Fig. 2B).
For comparison, the conventional non-serial-sectioning analysis
method was used to analyze thrombus number and size by calculating
the number and sum of thrombus areas in selected non-serial sections
at intervals of 300 μm. With the non-serial method, the total number of
thrombi obtained in the same three blocks was 6, 35 and 2 respectively,
greatly decreasedwhen comparedwith the data (78, 61 and10) obtained
from serial sectioning analysismethod. The thrombus areawas distribut-
ed among the 0.1-1, 1-10, 10-100 and N100 × 105 μm2 categories
(Fig. 2C). According to frequency distribution of size, most thrombi
(23/43, 53.5%)were 10-100×105 μm2 (Fig. 2D). From the above data, ob-
viously the serial sectioningmethod detectedmore thrombi (149) versus
non-serial method (43). Furthermore, we also detected themaximal area
and minimal area of each thrombus, and found a signiﬁcantly larger
range of thrombus size detected with serial sectioning method (from
2785612 μm2 to 5412.5 μm2) versus that with conventional non-serial
sectioning method (from 2539869 μm2 to 6093.75 μm2) (Fig. 2E).
Immuno-histological Evaluation of the Thrombi
Both the female and male mice injected with thrombus fully devel-
oped APTE. By Immuno/chemical-histological staining and evaluation
of the thrombi, no difference was detected between female andTable 2
Distribution of all PTEs in pulmonary blood vessels identiﬁed using two analysis methods.











All PTE mouse models were analyzed using both the serial-sectioning analysis method and themale mice about the constitutive ratio for each of the three major com-
ponents of thrombus: the aggregated platelets, ﬁbrin and erythrocytes
(Table 3).
Gender Differences in BMSCs Therapy Against APTE
Using serial sectioning analysis methods described above, we inves-
tigated whether transplanting BMSCs would enhance PTE resolution
and whether there are gender differences in BMSCs therapy. Cultured
female and male BMSCs were injected intravenously into female and
male mice in a sex-matched or –mismatched way at 4 h, 8 h, and 16 h
after thrombus induction. With the serial-sectioning analysis method,
the data demonstrated that, both female and male BMSCs possessed
therapeutic efﬁcacies against PTE in either gender of mice in the 4 h,
8 h and 16 h groups except for male BMSCs to male PTE mice in the
16 h groups (Fig. 3A-F). In the 4 h groups, regardless of gender of the
receiver, female BMSCs always produced a greater effect in decreasing
the thrombi size compared with the male cells (Fig. 2A and B). In the
8 h and 16 h groups, the female BMSCs produced better function in
male mice and no difference in female mice (Fig. 3C-F).
Gender Difference of GAPDH Expression in BMSCs is Critical for Gender
Difference in BMSC Therapy Against APTE
The distinct gender difference of BMSC treatment against APTE
revealed by the serial-sectioning analysis method piqued our interest.
As we have just reported in the previous work about BMSCs therapy
in pulmonary arterial hypertension [17], we unexpectedly found female
BMSCs always possessed a higher GAPDH protein expression level than
their male counterparts. Furthermore, we veriﬁed GAPDH played an es-
sential role in determining the superior functions of female BMSCs
























conventional non-serial-sectioning analysis method.
Fig. 2. An external validation study of the two analysismethods in lungbiopsy of patients. (A) By the serial sectioning analysismethod and PTE volume calculation, totally 149 thrombi
were found, 78, 61 and 10 in each of the 3 blocks respectively. The volumes of the 149 thrombi were divided into 5 categories: b0.1, 0.1-1, 1-10, 10-100, and N100 × 107 μm3.
(B) Summarization of the frequency distribution of the thrombus size in volume. (C) By the conventional method with non-serial sectioning at 300-μm intervals and PTE area calculation,
there were 43 thrombi, 6, 35 and 2 in each of the 3 blocks. The areas of thrombi were distributed into the categories: 0.1-1, 1-10, 10-100, and N 100 × 105 μm2. (D) Summarization of the
frequency distribution of the thrombus size in area. (E) Comparison of mean area, mean maximal area and mean minimal area of PTEs between the two analysis methods. (n = 3 lung
tissue blocks from three patients, ~1.0 cm × 1.0 cm × 0.2 cm size for each).
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C57BL/6 J mice. To investigate whether the higher GAPDH expression
was also responsible for the better therapeutic efﬁcacy of female
BMSCs, we manipulated GAPDH protein expression in male and
female BMSCs with GAPDH-over-expressing plasmid (OE-GAPDH)
and speciﬁc siRNA-GAPDH plasmid, respectively (Fig. 4A). As shown
in Fig. 4B and C, in both male and female mice, siRNA knockdown of
GAPDH resulted in the functional loss of female BMSCs in their superior
improvement of thrombus resolution, whereasmale BMSCs transfected
with OE-GAPDH gained greater therapeutic efﬁciency against PTE by
decreasing the thrombus size (P b 0.05). These data strongly suggest
that the GAPDH protein plays a critical role in superior therapeutic
efﬁcacy of female BMSCs against APTE.Table 3
Immuno and chemical-histological evaluation about components of the thrombi from
male and female APTE mice.
male (n = 20) female (n = 15) p value
ﬁbrin (%) 52.14 ± 3.96 47.21 ± 2.65 0.474
GPIIb/IIIa (%) 49.67 ± 2.68 42.30 ± 2.32 0.590
glycophorin A (%) 31.16 ± 2.01 36.58 ± 2.52 0.310
For each major component of thrombi, aggregated platelets, ﬁbrin, and erythrocytes, the
ratio of positively stained areas per thrombus areawas calculated and compared between
thrombi from male and female mice (n = 20 for male, n = 15 for female).Possible Mechanism of the Role of GAPDH in Gender Differences in the
Therapeutic Efﬁcacy of BMSCs on APTE
Exogenous GFP-expressing BMSCs were administered to male and
female mice 4 h after thrombus injection. The lungs were harvested
24 h later for morphological observation. Using immunoﬂuorescent
staining and imaging, we detected that some thrombi contained
GFP-expressing BMSCs. These cells were situated around the perimeter
of the thrombus (Fig. 4D).
Previous studies suggested urokinase-type plasminogen activator
(u-PA) production was a possible mechanism of normal bone marrow
transplantation in early thrombus resolution because the thrombus
failed to resolve in u-PA knockout mice but was restored by bone
marrow transplantation [5,11]. In this study, we investigated whether
manipulating GAPDH could inﬂuence u-PA expression. Western blot
analysis demonstrated that u-PA expression decreased in siRNA-
GAPDH transfected female BMSCs, whereas increased with OE-GAPDH
transfection of male BMSCs (Fig. 4E).Effectiveness of BMSCs Against APTE Un-revealed by Non-serial Sectioning
To reveal whether the serial sectioning analysis is necessary for
revealing the effectiveness of BMSCs in the treatment of APTE, the slides
of the same APTE mice (summarized in Fig. 1) were analyzed using the
non-serial sectioning method. Contrary to the signiﬁcant therapeutic
Fig. 3. Therapeutic efﬁcacy of BMSCs against APTE using serial-sectioning analysis method. (A,B) The therapeutic efﬁcacy of male BMSC (M-BMSC) or female BMSC (F-BMSC) treat-
ment in sex-matched and -mismatched inmale (A) and femal (B) PTEmice 4 h after thrombi injection. A, n= 6; B, n= 6. (C,D) The therapeutic efﬁcacy ofM-BMSC or F-BMSC treatment
in sex-matched and –mismatched in male (C) and femal (D) PTE mice 8 h after thrombi injection. C, n = 6; D, n =6. (E,F) The therapeutic efﬁcacy of M-BMSC or F-BMSC treatment in
sex-matched and -mismatched in male (E) and femal (F) PTE mice 16 h after thrombi injection. E, n = 6; F, n = 6. * p b 0.05.
996 X. Peng et al. / Thrombosis Research 135 (2015) 990–999effects of BMSCs revealed by serial sectioning analysis method, by the
non-serial-sectioning counterpart, neither gender of the BMSCs demon-
strated therapeutic efﬁcacy in either gender of APTE mice in any of the
4 h, 8 h and 16 groups (Fig. 5). Moreover, in a number of the groups
such as the male BMSCs to female mice in the 4 h groups, BMSC treat-
ment appeared to aggravate PTE formation (Fig. 5).
Discussion
APTE is a signiﬁcant health care concern, representing a major
source of mortality and morbidity, but lack of satisfactory treatment.
Given that it is difﬁcult to obtain human samples to study the disease
in most cases, laboratory research using animal models is necessary to
search for a new treatment strategy. There has always been an interest
in the development of animal models of thrombus to mimic the human
condition. Initial labors were centered on development of largemammal
models [21,22]. Mousemodels arose later in laboratory experiments due
to their advantages, such as relatively low cost and the availability of
different genetically manipulated strains. Because of the important
differences from humans, including body size and vessel size, such
small animal models require an appropriate analysis method.
Unlike former studies in which the size of thrombi were recorded as
either the area, diameter, weight or length [5,6,23,24], in the present
study, we were able to obtain the volume for each individual thrombus
by serial sectioning of the entire lungs from APTE mice. With such ananalysis method, we detected 165 thrombi in 84 APTE mice, and the
thrombus area ranged from 28247.91 μm2 to 4231.25 μm2. While
using the conventional non-serial sectioning and area-based analysis
method, the total number of thrombi was only 76, with 89 out of
165 thrombi (89/165, 54%) missed; and the thrombus area ranged
from 12921.03 μm2 to 12571.67 μm2. With greatly increased number
of detected thrombi and thrombus area range, the serial sectioning
method showed signiﬁcant superiority against conventional non-serial
sectioning method.
In order to further verify the superiority of serial sectioningmethod,
we made an external study on 3 lung tissue blocks from 3 patients
originally suspected of PTE. Consistently, the serial sectioning method
demonstrated more thrombi and a larger size range for thrombus that
can be detected.
As far as we know, in previous studies, few efforts were made to an-
alyze the distribution of PTE throughout the lung after the PTE models
were successfully established. Though a few documents mentioned
the distribution of PTE, the datawere obtained from the clinical patients
via radiographic inspection [25,26].Whenwe investigated PTE distribu-
tion in bilateral lungs using both serial sectioning and non-serial
sectioning methods, the data consistently indicated that most thrombi
were located in the lower lobe of the right lung, in the upper lobe
of the left lung, and in smaller blood vessels regardless of the mouse
gender. Such distribution presented a high degree of similarity in
thrombus distribution detected in clinical PTE patients via radiological
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injection-induced PTE mouse model for experimental research on PTE.
Evaluating the efﬁcacy of a new treatment against PTE in laboratory
experiments is dependent on studying a reliable animal model with an
appropriate analysismethod. In this study, we tested the reliability of an
APTE mouse model, developed serial sectioning analysis method for
PTE, and provided detailed and objective data on PTE distribution in
both the pulmonary lobes and the blood vessels in the lung. In addition,
the size of PTE was expressed in volume, but not in area or diameter. It
is known that imaging techniques such as micro-CT or the use of
radiolabelled ﬁbrinogen in the clot together with γ camera analysis
seem easier for thrombus size quantiﬁcation. However, the sensitivity
and speciﬁcity was around 71.0% versus 100%, and 84.4% versus 96.9%,
compared with histopathologic results from the non-serial sectioning
analysis method [28], and the tiny fragmented clots were beyond the
spatial resolution of the γ-camera and were not detectable [29].
Serial sectioning method has been used in histopathological studies
either in small sized animals [30,31] and human samples [32]. In those
works in small animals (such as rat andmice), serial sectioningwas per-
formed in eitherwhole or part of the hearts for non-thrombosis diseases
[30,31]. Serial sectioning method has been also used for detecting
pulmonary changes in patients and successfully identiﬁed thrombi in
lung [32]. In the previous studywith lung biopsy [32], a few representa-
tive blocks of the lung tissue were embedded and serial sectioned andFig. 4. Manipulation of GAPDH expression in BMSCs and the reverse test in male and fe
expression in BMSCs manipulated with GAPDH plasmids. (A) Representative western blot
densities of GAPDH in western blot assay. The GAPDH density was normalized using the β-
group (A upper). Representative western blot analysis for GAPDH in BMSCs; β-actin served a
size ratio (%) in male mice with APTE after BMSC treatment with manipulated GAPDH expres
manipulated GAPDH expressions. The control group served as 100%. * p b 0.05, male, n = 8;
thrombus (T). The sections were counterstained with DAPI to highlight the nucleus (blue). Ba
a control for equal protein loading. Band densities of u-PA in western blot assay. The GAPDH
of the mean value of the female control group (E upper). n = 4 for each, * p b 0.05. Representa
loading (E lower).no comparison between serial versus non-serial section was made
[32]. To the best of our knowledge, there is no yet any report about serial
sectioning of thewhole lungs to investigate PTEs, nor any study trying to
obtain thrombus volume by serial sectioningmethod. Andmore impor-
tantly, there is no a study reporting a carful comparison between serial
and non-serial sectioning for thrombosis. The full and precise details
about thrombus number, area and volume revealed in the current
study strongly indicate the superiority of serial sectioning method
over non-serial one.
With this reliable APTEmousemodel and the superior serial section-
ing method, we here undertook the challenge to determine the role of
BMSCs treatment on APTE. The effects of stem cell administration on
thrombus formation or dissolution remain disputable in recent years.
Previous studies documented two contrary opinions about the relation-
ship between stem cell therapy and APTE. Some clinical studies and
animal experimental studies indicated that intravenous administration
of stem cells facilitated PTE development [8–10,27], while others
implied transplantation of stem cells may be a therapeutic option
for treating solitary deep venous thrombosis [6,11,12]. However, so
far there has been no study investigating the function of BMSCs on
established or existed PTEs which containing multiple thrombi, nor
the gender difference of therapeutic efﬁcacy of BMSCs on APTE. There-
fore in this study with thrombus injection-induced APTE mouse
model, we attempted to determine the role of BMSCs in APTE. Usingmale APTE mice, recruitment of GFP-expressing BMSCs in the thrombus and u-PA
analysis for GAPDH in BMSCs; β-actin served as a control for equal protein loading. Band
actin level and then expressed as a percentage of the mean value of the female control
s a control for equal protein loading (A lower). n = 4 for each. * p b 0.05. (B) Thrombus
sions. (C) Thrombus size ratio (%) in female mice with APTE after BMSC treatment with
female, n = 8. (D) Localization of GFP-expressing BMSCs (green) in the perimeter of the
r = 50 μm. (E) Representative western blot analysis for u-PA in BMSCs; β-actin served as
u-PA density was normalized using the β-actin level and later expressed as a percentage
tive western blot analysis for u-PA in BMSCs; β-actin served as a control for equal protein
Fig. 5. Therapeutic efﬁcacy of BMSCs against APTE using non-serial sectioning analysis method. (A,B) The therapeutic efﬁcacy of male BMSC (M-BMSC) or female BMSC (F-BMSC)
treatment in sex-matched and -mismatched inmale (A) and femal (B) PTEmice 4 h after thrombi injection. A, n= 6; B, n= 6. (C,D) The therapeutic efﬁcacy of M-BMSC or F-BMSC treat-
ment in sex-matched and –mismatched inmale (C) and femal (D) PTEmice 8 h after thrombi injection. C, n=6;D, n=6. (E,F) The therapeutic efﬁcacy ofM-BMSC or F-BMSC treatment in
sex-matched and -mismatched in male (E) and femal (F) PTE mice 16 h after thrombi injection. E, n = 6; F, n = 6. * p b 0.05.
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ment demonstrated a statistically signiﬁcant effect on APTE (Fig. 5);
however, using the serial-sectioning analysis method, both genders
of the BMSCs possessed marked therapeutic efﬁcacy (Fig. 3). Our
data not only suggested the superiority and necessity of the serial-
sectioning analysis method in APTE animal models with multiple
and various-sized thrombi, but also implied BMSCs administration a
promising treatment strategy against APTE.
Recent documents indicated that the gender of stem cells is a signif-
icant determinant for therapeutic efﬁciency and therefore should be
taken into consideration [14–17]. Since in different disease models,
different gender of stem cells (either female or male) showed a better
therapeutic effect, gender differences on stem cell therapywere consid-
ered as tissue or disease speciﬁc [17]. In this study, we did not ﬁnd any
gender differences in the major thrombus ingredients including aggre-
gated platelets, ﬁbrin and erythrocytes between male and female
mice. However, we reported for the ﬁrst time that there was gender dif-
ference about BMSCs treatment against APTE, and the female BMSCs
possessed superior function in APTE resolution regardless of the sex of
host. This indicates that the superiority of female BMSCs against APTE
is probably controlled by the innate properties of themselves.
Previous documents have raised several contributors on the under-
lying mechanism about gender differences of stem cell therapy, such
as sex steroid hormones [14,15] and intracellular signalling pathways
[33]. In our latest work, the data strongly suggested the ‘housekeeping’protein GAPDH, which has been revealed as a multifunctional protein
with diverse activities instead [34], played a pivotal role in determining
their better therapeutic efﬁcacy of female BMSCs on pulmonary hyper-
tension compared to male cells [17]. In the current study, we used the
same BMSCs isolated and cultured from C57BL/6 J mice, which also
demonstrated gender difference of GAPDH expression. Therefore, we
postulated here that GAPDH would also contribute to the better thera-
peutic power of female BMSCs against APTE. Similarly, by manipulating
GAPDH expression with siRNA-GAPDH or OE-GAPDH in female or male
BMSCs, the gender difference in their therapeutic efﬁcacy against APTE
was reversed. These data strongly suggest that GAPDH plays a key role
in the superior function of female BMSCs.
We further tested the possible mechanism of GAPDH function, even
though it was not our emphasis for this study. Currently, a popular
theory indicates thrombus resolution is a process that is similar to the for-
mation of granulation tissue during wound healing [11,35]. However, in
this present study, since we investigated a very early stage of PTE, there
was no new capillary formation and recanalization within the thrombi,
as discovered by Modarai B et al at 7 days after EPC injection [11]. We
only found BMSCs in the periphery of some thrombi 24 h after exogenous
GFP-expressing BMSCs transplantation using ﬂuorescence staining and
imaging. Therefore, we inferred that there was some other mechanism
about the role of BMSCs on thrombus resolution.
u-PA is an important naturally occurring ﬁbrinolytic agent for early
thrombus resolution [36,37] its deﬁciency is associated with ﬁbrin
999X. Peng et al. / Thrombosis Research 135 (2015) 990–999deposition [38]. A recent study in ApoE-/-mice determined that unde-
tectable u-PA correlated with a decrease in vein wall MMP-2, MMP-9,
and MCP-1 expression and a decrease in monocyte recruitment, which
greatly contribute to thrombus resolution [39]. In this study usingwest-
ern blot analysis, we discovered that GAPDH markedly inﬂuenced the
expression of u-PA, an important protein in early thrombi resolution.
With the primary investigation, we postulated that GAPDH likely
contributes to thrombus resolution by regulating u-PA protein expres-
sion and therefore plays a key role in the superior function of
female BMSCs. However, this hypothesis needs to be veriﬁed in future
investigations.
In this study, we revealed the therapeutic role of BMSCs administra-
tion against APTE and the importance of serial sectioning analysis
method in evaluating the effect of a new treatment approach on
multiple thrombi. Though this analysis method involves tedious, time-
consuming procedures to obtain serial sections and histological obser-
vations of all of the pulmonary lobes, it is technically simple to perform,
easily reproducible, and generates abundant data on PTE. It may be not
obligatory for studies about solitary deep vein thrombus, but, this
technique will most likely facilitate studies on multiple PTEs in the
future.
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